A new, potent therapeutic agent to treat asthma is on the horizon, according to findings published on May 12th 2014 in Proceedings of the National Academy of Sciences show promise for, a chronic disease affecting more than 25 million Americans. The research study was done at Sanford-Burnham Medical Research Institute in Orlando, the Max Planck Institute for Colloids and Interfaces in Germany, the Free University of Berlin in Germany, Shinshu University in Japan, and the University of California, San Diego.